ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: Six Major NIH Positions Now Open; M.D. Anderson Plans More Than $25 Million In Construction

August 21, 1981

In Brief: Carnegie Mellon President Emeritus honored By UPCI; Schiffer Leaves Maryland for Detroit

October 17, 1997

Advisory Council To Be Named For Alternative Medicine Cuts

May 27, 1994

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995

House May Add $80 Million To NCI Budget For FY 1984

September 16, 1983

Hrushesky To Pursue Chronobiology Work At Albany, Forms Group

April 28, 1989